The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety. PRADAXA LAWSUIT STATUS: In May 2014, Boehringer Ingelheim and attorneys for plaintiffs reached a Pradaxa settlement agreement for $650 million, which would resolve about 4,000 Pradaxa bleeding lawsuits.…
A Hawaii judge has ordered the makers of Plavix to pay $834 million for not providing adequate warning that the blood thinner may be ineffective for much of the state’s population.…
A new study finds Brilinta is no better than Plavix at preventing adverse events after heart stent surgery.…
A new study warns that giving COVID-19 patients the blood thinner heparin may increase their risk of blood clots.…
A new study finds that doctors often fail to prescribe proper heart medications to cancer patients, who have an increased risk of cardiovascular disease.…
The blood thinner Xarelto is linked to severe and potentially deadly bleeding events. Product liability lawyers are investigating potential Xarelto lawsuits.…
A new study indicates Xarelto carries greater risks of bleeding events and death for recent heart valve replacement patients.…
The FDA is warning consumers not to use pre-owned test strips for monitoring glucose or blood thinners, due to a number of potential risks.…
A proposed $775 million settlement agreement could resolve nearly all outstanding Xarelto bleeding injury lawsuits.…
A new study finds that while Eliquis could prevent dangerous blood clots in cancer patients, it also doubles their risk of suffering major bleeding events.…
